Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cellular Signalling

• Publication date

  2011-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cellsig.2011.06.016PMID 21726628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mammalian Polo-like Kinase 1-dependent Regulation of the PBIP1-CENP-Q Complex at Kinetochores*

  2011cited by this paper
• Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics

  2010cited by this paper
• Targeting Polo-like Kinase in Cancer Therapy

  2010cited by this paper
• Mitotic DNA damage response: Polo-like Kinase-1 is dephosphorylated through ATM-Chk1 pathway

  2010cited by this paper
• Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos

  2010cited by this paper
• p53-dependent repression of polo-like kinase-1 (PLK1)

  2010cited by this paper
• DNA damage and polyploidization.

  2010cited by this paper
• Targeting the p53 pathway of apoptosis.

  2010cited by this paper
• The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

  2010cited by this paper
• Mechanisms of drug-induced mitotic catastrophe in cancer cells.

  2010cited by this paper
• Cell cycle, CDKs and cancer: a changing paradigm

  2009cited by this paper
• Mechanisms underlying the pro-survival pathway of p53 in suppressing mitotic death induced by adriamycin.

  2008cited by this paper
• Death through a tragedy: mitotic catastrophe

  2008cited by this paper
• Regulation of Polo-like Kinase 1 by DNA Damage in Mitosis

  2007cited by this paper
• Chemotherapeutic approaches for targeting cell death pathways.

  2006cited by this paper
• Mitotic Catastrophe Results in Cell Death by Caspase-Dependentand Caspase-Independent Mechanisms

  2006cited by this paper
• Genetic instability in cancer cells by impaired cell cycle checkpoints

  2006cited by this paper
• DNA damage checkpoints in mammals.

  2006cited by this paper
• Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis.

  2006cited by this paper
• p53 is a NF‐Y‐ and p21‐independent, Sp1‐dependent repressor of cyclin B1 transcription

  2005cited by this paper
• Chromosomal Instability Induced by Pim-1 Is Passage-dependent and Associated with Dysregulation of Cyclin B1*

  2005cited by this paper
• Getting in and out of mitosis with Polo-like kinase-1

  2005cited by this paper
• Polo-like kinases (Plks) and cancer

  2005cited by this paper
• The Prosurvival Activity of p53 Protects Cells from UV-Induced Apoptosis by Inhibiting c-Jun NH2-terminal Kinase Activity and Mitochondrial Death Signaling

  2004cited by this paper
• Cell death by mitotic catastrophe: a molecular definition

  2004cited by this paper
• Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints.

  2004cited by this paper
• Polo-like kinases and the orchestration of cell division

  2004cited by this paper
• Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells.

  2004cited by this paper
• Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation*

  2004cited by this paper
• Decision making by p53: life, death and cancer

  2003cited by this paper
• Cell cycle dependent expression of Plk1 in synchronized porcine fetal fibroblasts

  2003cited by this paper
• Identification of Promoter Elements Responsible for Transcriptional Inhibition of Polo-like Kinase 1 and Topoisomerase IIα Genes by p21WAF1/CIP1/ SDI1

  2002cited by this paper
• Inverse regulation of cyclin B1 by c-Myc and p53 and induction of tetraploidy by cyclin B1 overexpression.

  2001cited by this paper
• Polo-like kinase-1 is a target of the DNA damage checkpoint

  2000cited by this paper
• Surfing the p53 network

  2000cited by this paper
• Cell cycle regulation by the Cdc25 phosphatase family.

  2000cited by this paper
• p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor*

  1999cited by this paper
• Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content.

  1996cited by this paper
• A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis

  1996cited by this paper
• A transcriptionally active DNA-binding site for human p53 protein complexes

  1992cited by this paper

• Clinical relevance of PLK1 in epithelial ovarian cancer

  2025cites this paper
• Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers.

  2024cites this paper
• The Casein Kinase 2 Inhibitor CX-4945 Promotes Cholangiocarcinoma Cell Death Through PLK1

  2022cites this paper
• Polo-like kinase 1 (PLK1) signaling in cancer and beyond.

  2021cites this paper
• Synergistic apoptotic effect of miR-183-5p and Polo-Like kinase 1 inhibitor NMS-P937 in breast cancer cells

  2021cites this paper
• AMPK Activity Contributes to G2 Arrest and DNA Damage Decrease via p53/p21 Pathways in Oxidatively Damaged Mouse Zygotes

  2020cites this paper
• Synthetic curcumin derivative DK1 possessed G2/M arrest and induced apoptosis through accumulation of intracellular ROS in MCF-7 breast cancer cells

  2017cites this paper
• Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.

  2017cites this paper
• Necrobiology of Liver Cancer: Other Forms of Cell Death Related or not Related to Apoptosis

  2016cites this paper
• Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage

  2014cites this paper
• Strategies to identify novel therapeutic targets for oesophageal adenocarcinoma

  2014cites this paper
• Polo-like kinase-1 in DNA damage response

  2014cites this paper
• The role of polo-like kinase 1 in carcinogenesis: cause or consequence?

  2013cites this paper
• University of Birmingham Inhibition of Plk1 and Cyclin B1 expression results in panobinostat-induced G delay and mitotic defects

  2013cites this paper
• Inhibition of Plk1 and Cyclin B1 expression results in panobinostat-induced G delay and mitotic defects G and

  2013cites this paper
• Inhibition of Plk1 and Cyclin B1 Expression Results in Panobinostat-Induced G2 Delay and Mitotic Defects

  2013cites this paper
• A Small-Molecule Inhibitor Targeting the Mitotic Spindle Checkpoint Impairs the Growth of Uterine Leiomyosarcoma

  2012influential citation
• Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells.

  2012cites this paper